Moffitt

Tampa, Florida 33612

3 studies enrolling now · 12 studies all time

What they study most

Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Post Cytotoxic Therapy, Acute Myeloid Leukemias, Advanced Cancer, Advanced Solid Tumors, BK Virus Infection, Brain Tumor, Breast Neoplasms, CMML, Cholangiocarcinoma

Studies at this site

• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — Recruiting now
• A Study of LY4337713 in Participants With FAP-Positive Solid Tumors — Recruiting now
• A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
• A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) — Recruiting now
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors — Recruiting now
• MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas — Running, not enrolling
• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study — Completed
• A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) — Stopped early
• Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) — Stopped early
• Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma — Status unconfirmed
• Immunotherapy Study for Surgically Resected Pancreatic Cancer — Completed